Advertisement
Advertisement
HCAT
Health Catalyst, Inc Common Stock
1.71
USDSponsored
+0.01
+0.59%
Aug 18, 15:59 UTC -4
Closed
After-Market
1.82
+0.11
+6.73%
HCAT Earnings Reports
Positive Surprise Ratio
HCAT beat 25 of 29 last estimates.
86%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$60.92M
/-$0.01
Implied change from Q2 26 (Revenue/ EPS)
-13.57%
/-125.00%
Implied change from Q3 25 (Revenue/ EPS)
-20.18%
/-116.67%
Health Catalyst, Inc Common Stock earnings per share and revenue
On Aug 06, 2026, HCAT reported earnings of 0.04 USD per share (EPS) for Q2 26, beating the estimate of 0.03 USD, resulting in a 29.03% surprise. Revenue reached 70.49 million, compared to an expected 70.44 million, with a 0.07% difference. The market reacted with a -25.11% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 60.92 million USD, implying an decrease of -125.00% EPS, and decrease of -13.57% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
CapsoVision, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-12.02%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.23
Surprise
+7.67%
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
Neuraxis, Inc.
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.19
Surprise
+41.79%
P3 Health Partners Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$1.93
Actual
-$0.63
Surprise
+67.41%
Hims & Hers Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.01
Actual
-$0.10
Surprise
-599.30%
Heartflow, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.07
Surprise
+48.68%
MDxHealth SA Ordinary Shares
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+9.04%
FAQ
What were Health Catalyst, Inc Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Health Catalyst, Inc Common Stock reported EPS of $0.04, beating estimates by 29.03%, and revenue of $70.49M, 0.07% above expectations.
How did the market react to Health Catalyst, Inc Common Stock's Q2 2026 earnings?
The stock price moved down -25.11%, changed from $2.31 before the earnings release to $1.73 the day after.
When is Health Catalyst, Inc Common Stock expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Health Catalyst, Inc Common Stock's next earnings report?
Based on 10
analysts, Health Catalyst, Inc Common Stock is expected to report EPS of -$0.01 and revenue of $60.92M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement